PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-15.68%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.11B
AUM Growth
-$188M
(-14%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
47.87%
Holding
199
New
48
Increased
49
Reduced
18
Closed
34
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$31.1M |
| 2 |
Humana
HUM
|
$20.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.6M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$13.9M |
| 5 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$12.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$68.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$11.8M |
| 3 |
Baxter International
BAX
|
$10.9M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$8.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$7.63M |
Sector Composition
| 1 | Healthcare | 92.2% |
| 2 | Consumer Discretionary | 0.11% |
| 3 | Industrials | 0.05% |
| 4 | Financials | 0.02% |
| 5 | Consumer Staples | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGLN
101
DELISTED
Magellan Health Services, Inc.
MGLN
| $596K | 0.05% |
8,772
+5,421
| +162% | +$368K |
|
102
AMN Healthcare
AMN
$760M
| $586K | 0.05% |
+17,428
| New | +$586K |
|
103
Icon
ICLR
$14B
| $570K | 0.05% |
7,585
+5,372
| +243% | +$404K |
|
104
HCA Healthcare
HCA
$95.4B
| $561K | 0.05% |
+7,186
| New | +$561K |
|
105
UnitedHealth
UNH
$279B
| $560K | 0.05% |
4,346
+2,706
| +165% | +$349K |
|
106
Gilead Sciences
GILD
$140B
| $553K | 0.05% |
6,024
+3,567
| +145% | +$327K |
|
|
INFI
107
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $527K | 0.05% |
100,000
+80,000
| +400% | +$422K |
|
108
Neurogene
NGNE
$284M
| $526K | 0.05% |
2,980
| – | – |
|
109
Elevance Health
ELV
$72.4B
| $521K | 0.05% |
+3,747
| New | +$521K |
|
|
ALPN
110
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $521K | 0.05% |
31,250
| – | – |
|
111
Molina Healthcare
MOH
$9.6B
| $519K | 0.05% |
8,052
+5,252
| +188% | +$339K |
|
112
Enanta Pharmaceuticals
ENTA
$189M
| $514K | 0.05% |
+17,507
| New | +$514K |
|
113
Hologic
HOLX
$14.7B
| $508K | 0.04% |
+14,732
| New | +$508K |
|
|
AMED
114
DELISTED
Amedisys
AMED
| $507K | 0.04% |
10,493
+5,845
| +126% | +$282K |
|
|
WCG
115
DELISTED
Wellcare Health Plans, Inc.
WCG
| $505K | 0.04% |
+5,448
| New | +$505K |
|
|
VWR
116
DELISTED
VWR Corporation
VWR
| $505K | 0.04% |
+18,657
| New | +$505K |
|
|
PRAH
117
DELISTED
PRA Health Sciences, Inc.
PRAH
| $502K | 0.04% |
+11,751
| New | +$502K |
|
118
McKesson
MCK
$85.9B
| $501K | 0.04% |
3,188
+2,009
| +170% | +$316K |
|
119
Stellantis
STLA
$26.4B
| $500K | 0.04% |
62,559
-32,531
| -34% | -$260K |
|
120
Universal Health Services
UHS
$11.6B
| $498K | 0.04% |
+3,989
| New | +$498K |
|
|
TARO
121
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $491K | 0.04% |
3,429
+1,936
| +130% | +$277K |
|
|
GNVC
122
DELISTED
GenVec, Inc.
GNVC
| $489K | 0.04% |
60,664
-920
| -1% | -$7.42K |
|
|
SYNH
123
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $488K | 0.04% |
+11,846
| New | +$488K |
|
124
Cardinal Health
CAH
$36B
| $487K | 0.04% |
+5,947
| New | +$487K |
|
|
AFAM
125
DELISTED
Almost Family Inc
AFAM
| $487K | 0.04% |
13,075
+8,186
| +167% | +$305K |
|